List of Tables
Table 1. Global Fibroblast Growth Factor Receptor 4 Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Fibroblast Growth Factor Receptor 4 Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Fibroblast Growth Factor Receptor 4 Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Fibroblast Growth Factor Receptor 4 Covered in This Study
Table 5. Global Fibroblast Growth Factor Receptor 4 Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Fibroblast Growth Factor Receptor 4 Sales Share by Manufacturers (2016-2021)
Table 7. Global Fibroblast Growth Factor Receptor 4 Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Fibroblast Growth Factor Receptor 4 Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Fibroblast Growth Factor Receptor 4 Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Fibroblast Growth Factor Receptor 4 Manufacturing Sites and Area Served
Table 11. Manufacturers Fibroblast Growth Factor Receptor 4 Product Type
Table 12. Global Fibroblast Growth Factor Receptor 4 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Fibroblast Growth Factor Receptor 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibroblast Growth Factor Receptor 4 as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Fibroblast Growth Factor Receptor 4 Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Region (2016-2021)
Table 17. Global Fibroblast Growth Factor Receptor 4 Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Fibroblast Growth Factor Receptor 4 Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Fibroblast Growth Factor Receptor 4 Sales Market Share by Country (2016-2021)
Table 20. North America Fibroblast Growth Factor Receptor 4 Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Fibroblast Growth Factor Receptor 4 Revenue Market Share by Country (2016-2021)
Table 22. Europe Fibroblast Growth Factor Receptor 4 Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Fibroblast Growth Factor Receptor 4 Sales Market Share by Country (2016-2021)
Table 24. Europe Fibroblast Growth Factor Receptor 4 Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Fibroblast Growth Factor Receptor 4 Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Fibroblast Growth Factor Receptor 4 Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Fibroblast Growth Factor Receptor 4 Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Fibroblast Growth Factor Receptor 4 Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Fibroblast Growth Factor Receptor 4 Revenue Market Share by Region (2016-2021)
Table 30. Latin America Fibroblast Growth Factor Receptor 4 Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Fibroblast Growth Factor Receptor 4 Sales Market Share by Country (2016-2021)
Table 32. Latin America Fibroblast Growth Factor Receptor 4 Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Fibroblast Growth Factor Receptor 4 Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Fibroblast Growth Factor Receptor 4 Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Fibroblast Growth Factor Receptor 4 Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Fibroblast Growth Factor Receptor 4 Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Fibroblast Growth Factor Receptor 4 Revenue Market Share by Country (2016-2021)
Table 38. Global Fibroblast Growth Factor Receptor 4 Sales (K Pcs) by Type (2016-2021)
Table 39. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Type (2016-2021)
Table 40. Global Fibroblast Growth Factor Receptor 4 Revenue (Million US$) by Type (2016-2021)
Table 41. Global Fibroblast Growth Factor Receptor 4 Revenue Share by Type (2016-2021)
Table 42. Global Fibroblast Growth Factor Receptor 4 Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Fibroblast Growth Factor Receptor 4 Sales (K Pcs) by Application (2016-2021)
Table 44. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Application (2016-2021)
Table 45. Global Fibroblast Growth Factor Receptor 4 Revenue (Million US$) by Application (2016-2021)
Table 46. Global Fibroblast Growth Factor Receptor 4 Revenue Share by Application (2016-2021)
Table 47. Global Fibroblast Growth Factor Receptor 4 Price (USD/Pcs) by Application (2016-2021)
Table 48. Amgen Inc Corporation Information
Table 49. Amgen Inc Description and Business Overview
Table 50. Amgen Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Amgen Inc Fibroblast Growth Factor Receptor 4 Product
Table 52. Amgen Inc Recent Developments/Updates
Table 53. ArQule Inc Corporation Information
Table 54. ArQule Inc Description and Business Overview
Table 55. ArQule Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. ArQule Inc Fibroblast Growth Factor Receptor 4 Product
Table 57. ArQule Inc Recent Developments/Updates
Table 58. AstraZeneca Plc Corporation Information
Table 59. AstraZeneca Plc Description and Business Overview
Table 60. AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Product
Table 62. AstraZeneca Plc Recent Developments/Updates
Table 63. Blueprint Medicines Corp Corporation Information
Table 64. Blueprint Medicines Corp Description and Business Overview
Table 65. Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Product
Table 67. Blueprint Medicines Corp Recent Developments/Updates
Table 68. Bristol-Myers Squibb Co Corporation Information
Table 69. Bristol-Myers Squibb Co Description and Business Overview
Table 70. Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Product
Table 72. Bristol-Myers Squibb Co Recent Developments/Updates
Table 73. Eisai Co Ltd Corporation Information
Table 74. Eisai Co Ltd Description and Business Overview
Table 75. Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Product
Table 77. Eisai Co Ltd Recent Developments/Updates
Table 78. Eli Lilly and Co Corporation Information
Table 79. Eli Lilly and Co Description and Business Overview
Table 80. Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Product
Table 82. Eli Lilly and Co Recent Developments/Updates
Table 83. Genosco Inc Corporation Information
Table 84. Genosco Inc Description and Business Overview
Table 85. Genosco Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Genosco Inc Fibroblast Growth Factor Receptor 4 Product
Table 87. Genosco Inc Recent Developments/Updates
Table 88. H3 Biomedicine Inc Corporation Information
Table 89. H3 Biomedicine Inc Description and Business Overview
Table 90. H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Product
Table 92. H3 Biomedicine Inc Recent Developments/Updates
Table 93. Incyte Corp Corporation Information
Table 94. Incyte Corp Description and Business Overview
Table 95. Incyte Corp Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Incyte Corp Fibroblast Growth Factor Receptor 4 Product
Table 97. Incyte Corp Recent Developments/Updates
Table 98. Ionis Pharmaceuticals Inc Corporation Information
Table 99. Ionis Pharmaceuticals Inc Description and Business Overview
Table 100. Ionis Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Ionis Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Product
Table 102. Ionis Pharmaceuticals Inc Recent Developments/Updates
Table 103. Johnson & Johnson Corporation Information
Table 104. Johnson & Johnson Description and Business Overview
Table 105. Johnson & Johnson Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Johnson & Johnson Fibroblast Growth Factor Receptor 4 Product
Table 107. Johnson & Johnson Recent Developments/Updates
Table 108. Merrimack Pharmaceuticals Inc Corporation Information
Table 109. Merrimack Pharmaceuticals Inc Description and Business Overview
Table 110. Merrimack Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Merrimack Pharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Product
Table 112. Merrimack Pharmaceuticals Inc Recent Developments/Updates
Table 113. NGM Biopharmaceuticals Inc Corporation Information
Table 114. NGM Biopharmaceuticals Inc Description and Business Overview
Table 115. NGM Biopharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. NGM Biopharmaceuticals Inc Fibroblast Growth Factor Receptor 4 Product
Table 117. NGM Biopharmaceuticals Inc Recent Developments/Updates
Table 118. Novartis AG Corporation Information
Table 119. Novartis AG Description and Business Overview
Table 120. Novartis AG Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. Novartis AG Fibroblast Growth Factor Receptor 4 Product
Table 122. Novartis AG Recent Developments/Updates
Table 123. Principia Biopharma Inc Corporation Information
Table 124. Principia Biopharma Inc Description and Business Overview
Table 125. Principia Biopharma Inc Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 126. Principia Biopharma Inc Fibroblast Growth Factor Receptor 4 Product
Table 127. Principia Biopharma Inc Recent Developments/Updates
Table 128. Tasly Pharmaceutical Group Co Ltd Corporation Information
Table 129. Tasly Pharmaceutical Group Co Ltd Description and Business Overview
Table 130. Tasly Pharmaceutical Group Co Ltd Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 131. Tasly Pharmaceutical Group Co Ltd Fibroblast Growth Factor Receptor 4 Product
Table 132. Tasly Pharmaceutical Group Co Ltd Recent Developments/Updates
Table 133. Vichem Chemie Research Ltd Corporation Information
Table 134. Vichem Chemie Research Ltd Description and Business Overview
Table 135. Vichem Chemie Research Ltd Fibroblast Growth Factor Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 136. Vichem Chemie Research Ltd Fibroblast Growth Factor Receptor 4 Product
Table 137. Vichem Chemie Research Ltd Recent Developments/Updates
Table 138. Production Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Fibroblast Growth Factor Receptor 4 Distributors List
Table 141. Fibroblast Growth Factor Receptor 4 Customers List
Table 142. Fibroblast Growth Factor Receptor 4 Market Trends
Table 143. Fibroblast Growth Factor Receptor 4 Growth Drivers
Table 144. Fibroblast Growth Factor Receptor 4 Market Restraints
Table 145. Global Fibroblast Growth Factor Receptor 4 Sales Forecast by Type (2022-2027) & (K Pcs)
Table 146. Global Fibroblast Growth Factor Receptor 4 Sales Market Share Forecast by Type (2022-2027)
Table 147. Global Fibroblast Growth Factor Receptor 4 Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 148. Global Fibroblast Growth Factor Receptor 4 Revenue Market Share Forecast by Type (2022-2027)
Table 149. Global Fibroblast Growth Factor Receptor 4 Sales Forecast by Application (2022-2027) & (K Pcs)
Table 150. Global Fibroblast Growth Factor Receptor 4 Sales Market Share Forecast by Application (2022-2027)
Table 151. Global Fibroblast Growth Factor Receptor 4 Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 152. Global Fibroblast Growth Factor Receptor 4 Revenue Market Share Forecast by Application (2022-2027)
Table 153. Global Fibroblast Growth Factor Receptor 4 Sales Forecast by Region (2022-2027) & (K Pcs)
Table 154. Global Fibroblast Growth Factor Receptor 4 Sales Market Share Forecast by Region (2022-2027)
Table 155. Global Fibroblast Growth Factor Receptor 4 Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 156. Global Fibroblast Growth Factor Receptor 4 Revenue Market Share Forecast by Region (2022-2027)
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Fibroblast Growth Factor Receptor 4
Figure 2. Global Fibroblast Growth Factor Receptor 4 Market Share by Type in 2020 & 2027
Figure 3. BLU-9931 Product Picture
Figure 4. BMS-986036 Product Picture
Figure 5. Erdafitinib Product Picture
Figure 6. ES-135 Product Picture
Figure 7. FGF-401 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Fibroblast Growth Factor Receptor 4 Market Share by Application in 2020 & 2027
Figure 10. Breast Cancer
Figure 11. Lymphoma
Figure 12. Melanoma
Figure 13. Fallopian Tube Cancer
Figure 14. Lung Cancer
Figure 15. Others
Figure 16. Global Fibroblast Growth Factor Receptor 4 Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Fibroblast Growth Factor Receptor 4 Market Size 2016-2027 (US$ Million)
Figure 18. Global Fibroblast Growth Factor Receptor 4 Sales 2016-2027 (K Pcs)
Figure 19. Global Fibroblast Growth Factor Receptor 4 Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 20. Fibroblast Growth Factor Receptor 4 Sales Share by Manufacturers in 2020
Figure 21. Global Fibroblast Growth Factor Receptor 4 Revenue Share by Manufacturers in 2020
Figure 22. The Global 5 and 10 Largest Fibroblast Growth Factor Receptor 4 Players: Market Share by Revenue in 2020
Figure 23. Fibroblast Growth Factor Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 24. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Region (2016-2021)
Figure 25. Global Fibroblast Growth Factor Receptor 4 Sales Market Share by Region in 2020
Figure 26. Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Region (2016-2021)
Figure 27. Global Fibroblast Growth Factor Receptor 4 Revenue Market Share by Region in 2020
Figure 28. U.S. Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Canada Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Germany Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. France Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. U.K. Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Italy Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Russia Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Japan Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. South Korea Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. India Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Australia Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Taiwan Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Indonesia Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Thailand Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Malaysia Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Philippines Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Vietnam Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Mexico Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Brazil Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Argentina Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Turkey Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Saudi Arabia Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. U.A.E Fibroblast Growth Factor Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. Sales Market Share of Fibroblast Growth Factor Receptor 4 by Type (2016-2021)
Figure 53. Sales Market Share of Fibroblast Growth Factor Receptor 4 by Application (2016-2021)
Figure 54. Sales Market Share of Fibroblast Growth Factor Receptor 4 by Application in 2020
Figure 55. Revenue Share of Fibroblast Growth Factor Receptor 4 by Application (2016-2021)
Figure 56. Revenue Share of Fibroblast Growth Factor Receptor 4 by Application in 2020
Figure 57. Manufacturing Cost Structure of Fibroblast Growth Factor Receptor 4
Figure 58. Manufacturing Process Analysis of Fibroblast Growth Factor Receptor 4
Figure 59. Fibroblast Growth Factor Receptor 4 Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

LIST OF FIGURE